Ja. Mclachlan et al., From malformations to molecular mechanisms in the male: three decades of research on endocrine disrupters, APMIS, 109(4), 2001, pp. 263-272
For three decades, we have known that estrogens alter the development of th
e mammalian reproductive system in predictable ways. In mice exposed prenat
ally to diethylstilbestrol (DES) or other estrogens, the male offspring exh
ibit structural malformations including cryptorchidism, epididymal cysts an
d retained Mullerian ducts. The estrogen-associated alterations in the geni
tal tract phenotype can be usefully considered as a model called Developmen
tal Estrogenization Syndrome. While estrogen treatment during critical peri
ods of morphogenesis of the male reproductive system has been associated wi
th these changes, the mechanisms at the molecular level are still being dis
covered. Parallel findings on the hormones involved in Mullerian duct regre
ssion and testicular descent have helped guide research on the mechanisms o
f developmental estrogenization of the male. Cellular localization of molec
ular signals associated with key steps in genital tract development, use of
mice with gene disruption, and knowledge of the mechanisms underlying pers
istent changes in gene expression are beginning to provide a blue print for
both the physiological role and pathological effects of estrogens in repro
ductive tract development. Since many of the same biological principles und
erlie genital tract morphogenesis in mammals, one may expect some of the sa
me changes in males of other species exposed to estrogen during the appropr
iate developmental periods.